S. Rizvi

发表

Current Treatment of Febrile Neutropenia: Tailored, Individual Based Therapy

B. Lim, S. Rizvi, 2015 .

Stem Cell Transplantation Therapy-induced Acute Lymphocytic Leukemia with the 11q23 Translocation: 2 Cases and a Review of the Literature

Monica Joshi, J. Drabick, H. Harvey, 2014 .

Leptomeningeal carcinomatosis as the only manifestation of disease in recurrent gastroesophageal cancers.

S. Rizvi, Yixing Jiang, K. Abbi, 2011, Gastrointestinal cancer research : GCR.

Bone‐Related Issues in Oncology

H. Collins, A. Lipton, S. Rizvi, 2014 .

Afatinib for the treatment of metastatic non-small cell lung cancer

C. Belani, M. Joshi, S. Rizvi, 2015, Cancer management and research.

Therapeutic approach guided by genetic alteration: Use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression

Z. Gatalica, J. Drabick, Jacob S. Lipkin, 2015, Cancer biology & therapy.

Pharmacogenetics in neuroendocrine tumors of the pancreas.

M. Saif, J. Wong, Yuxia Jia, 2014, JOP : Journal of the pancreas.

Abstract P6-07-06: Effect of serum biomarkers (activin A, CAIX, HER2, TIMP-1, and uPA) on outcome in HER2+ metastatic breast cancer patients treated in first line with lapatinib or trastuzumab combined with taxane: CCTG MA.31

Bingshu E. Chen, S. Aparicio, A. Richardson, 2017 .

A case of heterogeneous sensitivity to panitumumab in cetuximab-refractory colorectal adenocarcinoma metastases

W. El-Deiry, Zhaohai Yang, Nabeel E. Sarwani, 2015, Cancer biology & therapy.

Novel Immunotherapies for Hematological Malignancies.

K. Vrana, Xin Liu, Hong Zheng, 2016, Current molecular pharmacology.